Sort   by:  
 Page size 
UnknownMidostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial.
Not available
S-EPMC10632658 | biostudies-literature
UnknownHypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Not available
S-EPMC10867066 | biostudies-literature
UnknownAdded prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.
Not available
S-EPMC7218423 | biostudies-literature
UnknownDevimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial.
Not available
S-EPMC12082102 | biostudies-literature
Unknown<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.
Not available
S-EPMC11910791 | biostudies-literature
Sort   by:  
 Page size